ema glp-1 vision loss recommendation november 2025 Last month, the European Medicines Agency recommended that product information for #semaglutide medicines— the active ingredient in #Ozempic, #Rybelsus, and #Wegovy — be updated to include non-arteritic anterior ischemic optic neuropathy or # Weight-Loss Drug Lawsuits: What Patients

Description

My take: GLP-1RAs may become more than metabolic drugs, but oncology needs prospective cancer-outcome data before calling this prevention

Last week, Eli Lillys orforglipron has become the first oral, non-peptide GLP-1 receptor agonist to clear a Phase 3 trial, showing strong efficacy in reducing A1C (up to 1.6%) and body weight (up to 7.9%) in people with type 2 diabetes

Get Semaglutide GLP-1 Medical Weight Loss Injections in Canton, MI for Personalized Weight Loss Solutions.

Noom will offer compounded GLP-1 injections paired with Nooms powerful GLP-1 companion program, providing a sustainable pathway off the medications....